Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
Public ClinicalTrials.gov record NCT02611713. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Study identification
- NCT ID
- NCT02611713
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 213 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2016
- Primary completion
- Dec 23, 2020
- Completion
- Dec 23, 2020
- Last update posted
- Dec 14, 2021
2016 – 2020
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham - Main /ID# 144422 | Birmingham | Alabama | 35233 | — |
| Parkinson's Disease and Moveme /ID# 144413 | Boca Raton | Florida | 33486 | — |
| University of Florida - Archer /ID# 144415 | Gainesville | Florida | 32610 | — |
| University of Miami /ID# 144420 | Miami | Florida | 33138 | — |
| Georgia Regents University /ID# 144417 | Augusta | Georgia | 30912 | — |
| University of Kansas Health Sy /ID# 154242 | Kansas City | Kansas | 66160-8500 | — |
| University of Kentucky Chandler Medical Center /ID# 144421 | Lexington | Kentucky | 40536 | — |
| Johns Hopkins University /ID# 144416 | Baltimore | Maryland | 21287 | — |
| Mercy St. Mary's Health Center /ID# 144418 | Grand Rapids | Michigan | 49503 | — |
| Jared Neuroscience Center /ID# 161629 | Springfield | Missouri | 65804 | — |
| Washington University-School of Medicine /ID# 147235 | St Louis | Missouri | 63110 | — |
| Univ Nebraska Med Ctr /ID# 147655 | Omaha | Nebraska | 68198 | — |
| Wake Forest Univ HS /ID# 144419 | Winston-Salem | North Carolina | 27157 | — |
| Penn State Child Hosp.Hersh,PA /ID# 160671 | Hershey | Pennsylvania | 17033 | — |
| University of Pennsylvania /ID# 161135 | Philadelphia | Pennsylvania | 19104-5502 | — |
| Vanderbilt Univ Med Ctr /ID# 150782 | Nashville | Tennessee | 37232-0011 | — |
| University of Vermont Medical Center /ID# 144410 | Burlington | Vermont | 05401-1473 | — |
| King County Public Hospital /ID# 144412 | Kirkland | Washington | 98034 | — |
| Northwest Neurological, PLLC /ID# 144409 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02611713, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02611713 live on ClinicalTrials.gov.